
Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

